Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425,
Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3052, Australia, and.
J Neurosci. 2014 Jun 18;34(25):8605-11. doi: 10.1523/JNEUROSCI.1204-13.2014.
Relapse to cocaine seeking is associated with potentiated excitatory synapses in nucleus accumbens. α2δ-1 is an auxiliary subunit of voltage-gated calcium channels that affects calcium-channel trafficking and kinetics, initiates extracellular signaling cascades, and promotes excitatory synaptogenesis. Previous data demonstrate that repeated exposure to alcohol, nicotine, methamphetamine, and morphine upregulates α2δ-1 in reward-related brain regions, but it was unclear whether this alteration generalized to cocaine. Here, we show that α2δ-1 protein was increased in nucleus accumbens after cocaine self-administration and extinction compared with saline controls. Furthermore, the endogenous ligand thrombospondin-1, responsible for the synaptogenic properties of the α2δ-1 receptor, was likewise elevated. Using whole-cell patch-clamp recordings of EPSCs in nucleus accumbens, we demonstrated that gabapentin, a specific α2δ-1 antagonist, preferentially reduced the amplitude and increased the paired-pulse ratio of EPSCs evoked by electrical stimulation in slices from cocaine-experienced rats compared with controls. In vivo, gabapentin microinjected in the nucleus accumbens core attenuated cocaine-primed but not cue-induced reinstatement. Importantly, gabapentin's effects on drug seeking were not due to a general depression of spontaneous or cocaine-induced locomotor activity. Moreover, gabapentin had no effect on reinstatement of sucrose seeking. These data indicate that α2δ-1 contributes specifically to cocaine-reinstated drug seeking, and identifies this protein as a target for the development of cocaine relapse medications. These results also inform ongoing discussion in the literature regarding efficacy of gabapentin as a candidate addiction therapy.
复吸可卡因与伏隔核中兴奋性突触的增强有关。α2δ-1 是电压门控钙通道的辅助亚基,它影响钙通道的运输和动力学,启动细胞外信号级联反应,并促进兴奋性突触发生。先前的数据表明,反复暴露于酒精、尼古丁、冰毒和吗啡会使与奖赏相关的脑区中的 α2δ-1 上调,但尚不清楚这种改变是否普遍适用于可卡因。在这里,我们发现与盐水对照组相比,可卡因自我给药和消退后,伏隔核中的 α2δ-1 蛋白增加。此外,负责 α2δ-1 受体突触发生特性的内源性配体血小板反应蛋白-1 也升高。通过在伏隔核中进行 EPSC 的全细胞膜片钳记录,我们证明了加巴喷丁,一种特定的 α2δ-1 拮抗剂,优先降低了可卡因经验大鼠脑片中电刺激诱发的 EPSC 的幅度并增加了其成对脉冲比,而对照脑片则没有。在体内,将加巴喷丁微注射到伏隔核核心区域可减弱可卡因引发的但不能引发线索诱导的复吸。重要的是,加巴喷丁对觅药行为的影响不是由于自发或可卡因诱导的运动活动的普遍抑制。此外,加巴喷丁对蔗糖觅药的复吸没有影响。这些数据表明,α2δ-1 特异性地促进可卡因复吸的觅药行为,并将该蛋白鉴定为开发可卡因复吸药物的靶点。这些结果还为文献中关于加巴喷丁作为候选成瘾治疗药物的疗效的讨论提供了信息。